Efficacy of risankizumab rescue therapy in patients with moderately to severely active Crohn's Disease and inadequate response to risankizumab maintenance therapy

被引：0
|
作者：
Baert, F. J. [1 ]
Atreya, R. [2 ]
Kakuta, Y. [3 ]
Long, M. [4 ]
Roblin, X. [5 ]
Neimark, E. [6 ]
Song, A. [6 ]
Wallace, K. [6 ]
Kingys, K. [6 ]
Mallick, M. [6 ]
Liao, X. [6 ]
Lim, A. [7 ]
机构：
[1] AZ Delta, Dept Gastroenterol, Roeselare Menen, Belgium
[2] Friedrich Alexander Univ Erlangen Nurnberg, Dept Med, Univ Hosp Erlangen, Erlangen, Germany
[3] Tohoku Univ, Div Gastroenterol, Grad Sch Med, Seiryo Aoba Sendai, Miyagi, Japan
[4] Univ N Carolina, Div Gastroenterol & Hepatol, Multidisciplinary Ctr Inflammatory Bowel Dis, Chapel Hill, NC 27515 USA
[5] Univ Hosp St Etienne, Dept Gastroenterol, St Etienne, France
[6] AbbVie Inc, Dept Gastroenterol, N Chicago, IL USA
[7] John Flynn Private Hosp, Dept Gastroenterol, Tugun, Qld, Australia
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP85
引用
收藏
页码：I128 / I128
页数：1
相关论文
共 50 条
  • [41] Individual and comprehensive symptom resolution after induction and maintenance therapy with risankizumab in patients with moderately to severely active Ulcerative Colitis: A post-hoc analysis of INSPIRE and COMMAND studies
    da Silva Torres, J. Tinoco
    Panes, J.
    Siegel, C. A.
    Dubinsky, M. C.
    Dulai, P. S.
    Tanida, S.
    Danese, S.
    Levine, P.
    Lai, J. H.
    Sharma, D.
    Shukla, N.
    Remple, V.
    Hecht, P. M.
    Gonzalez, Y. Sanchez
    Panaccione, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I213 - I214
  • [42] SHORTER DISEASE DURATION IS ASSOCIATED WITH BETTER OUTCOMES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE TREATED WITH RISANKIZUMAB: RESULTS FROM THE PHASE 3 ADVANCE, MOTIVATE, AND FORTIFY STUDIES
    Peyrin-Biroulet, Laurent
    Colombel, Jean Frederic
    Louis, Edouard
    Ferrante, Marc
    Motoya, Satoshi
    Panaccione, Remo
    Torres, Joana
    Ungaro, Ryan C.
    Kligys, Kristina
    Kalabic, Jasmina
    Zambrano, Javier A.
    Zhang, Yafei
    D'Haens, Geert
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S978 - S978
  • [43] EFFICACY AND SAFETY OF GUSELKUMAB MAINTENANCE THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE: WEEK 48 ANALYSES FROM THE PHASE 2 GALAXI 1 STUDY
    Panaccione, Remo
    Rubin, David T.
    Sands, Bruce E.
    Reinisch, Walter
    D'Haens, Geert
    Panes, Julian
    Gonzalez, Susana
    Weisel, Kathleen
    Sahoo, Aparna
    Frustaci, Mary Ellen S.
    Yang, Zijiang
    Sandborn, William J.
    Afzali, Anita
    Hisamatsu, Tadakazu
    Danese, Silvio
    Andrews, Jane M.
    Feagan, Brian G.
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S216 - S217
  • [44] Efficacy of risankizumab induction and maintenance therapy by baseline Crohn's disease location: Post hoc analysis of the Phase 3 ADVANCE, MOTIVATE, and FORTIFY studies
    Bossuyt, P.
    Bresso, F.
    Dubinsky, M.
    Ha, C.
    Siegel, C.
    Zambrano, J.
    Kligys, K.
    Kalabic, J.
    Zhang, Y.
    Panaccione, R.
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2022, 37 : 154 - 156
  • [45] Adalimumab Therapy is Associated with Improvements in Clinical Laboratory Parameters in Patients with Moderately to Severely Active Crohn's Disease
    Rubin, David
    Ghosh, Subrata
    Bensimon, Arielle
    Yu, Andrew
    Wu, Eric
    Pollack, Paul
    Chao, Jingdong
    Mulani, Parvez
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 : S464 - S465
  • [46] Efficacy of risankizumab induction and maintenance therapy by baseline Crohn's Disease location: Post hoc analysis of the phase 3 ADVANCE, MOTIVATE, and FORTIFY studies
    Bossuyt, P.
    Bresso, F.
    Dubinsky, M.
    Ha, C.
    Siegel, C.
    Zambrano, J.
    Kligys, K.
    Kalabic, J.
    Zhang, Y.
    Panaccione, R.
    [J]. JOURNAL OF CROHNS & COLITIS, 2022, 16 : I048 - I048
  • [47] EFFICACY OF RISANKIZUMAB INDUCTION AND MAINTENANCE THERAPY BY BASELINE CROHN'S DISEASE LOCATION: POST HOC ANALYSIS OF THE PHASE 3 ADVANCE, MOTIVATE, AND FORTIFY STUDIES
    Bossuyt, Peter
    Bresso, Francesca
    Dubinsky, Marla
    Ha, Christina
    Siegel, Corey A.
    Zambrano, Javier A.
    Kligys, Kristina
    Kalabic, Jasmina
    Zhang, Yafei
    Panaccione, Remo
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S974 - S974
  • [48] Effectiveness and safety of risankizumab induction therapy for 100 patients with Crohn's disease: A GETAID multicentre cohort study
    Fumery, Mathurin
    Defrance, Antoine
    Roblin, Xavier
    Altwegg, Romain
    Caron, Benedicte
    Hebuterne, Xavier
    Stefanescu, Carmen
    Meyer, Antoine
    Nachury, Maria
    Laharie, David
    Nancey, Stephane
    Le Berre, Catherine
    Serrero, Melanie
    Geyl, Sophie
    Giletta, Cyrielle
    Ah-Soune, Philippe
    Duveau, Nicolas
    Uzzan, Mathieu
    Abitbol, Vered
    Biron, Amelie
    My-Linh Tran-Minh
    Paupard, Thierry
    Vuitton, Lucine
    Elgharabawy, Yasmine
    Peyrin-Biroulet, Laurent
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (04) : 426 - 434
  • [49] Efficacy of Risankizumab in Patients With Moderately to Severely Active Ulcerative Colitis by Prior Advanced Therapy Failure and Mechanism of Action: Post Hoc Analysis of the INSPIRE and COMMAND Phase 3 Studies
    Panaccione, R.
    Louis, E.
    Colombel, J. F.
    D'Haens, G.
    Peyrin-Biroulet, L.
    Dubinsky, M.
    Takeuchi, K.
    Kalabic, J.
    Levine, P.
    Neimark, E.
    Chen, S.
    Cheng, L.
    Duan, W. R.
    Vladea, R.
    Hecht, P. M.
    Gonzalez, Y. Sanchez
    Schreiber, S.
    Ferrante, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1146 - I1148
  • [50] Maintenance therapy with infliximab every 8 weeks is superior to every 12 weeks in maintaining response and remission in pediatric patients with moderately to severely active Crohn's disease
    Hyams, Jeffrey
    Crandall, Wallace
    Kugathasan, Subia
    Griffiths, Anne
    Olson, Allan
    Johanns, Jewel
    Liu, Grace
    Travers, Suzanne
    Heuschkel, Robert
    Markowitz, James
    Cohen, Stanley
    Winter, Harland
    Veereman-Wauters, Gigi
    Ferry, George
    Baldassano, Robert
    [J]. GASTROENTEROLOGY, 2006, 130 (04) : A12 - A12
12345